Cardiofaciocutaneous syndrome is an extremely rare genetic disorder and one of the RASopathies, a group of conditions caused by mutations affecting the MAP kinase signaling pathway. It results from mutations in the KRAS, BRAF, MEK1 and MEK2 genes and follows an autosomal dominant inheritance pattern. The syndrome presents with a distinctive facial appearance, unusually sparse, brittle and curly scalp hair, and skin abnormalities ranging from dermatitis to generalized ichthyosis. Heart malformations occur in over 75 percent of patients, alongside growth delays, feeding problems, intellectual disability, and foot abnormalities such as extra or fused toes, with affected infants often showing failure to thrive. Facial characteristics include an unusually large head, a prominent forehead, an upturned nose, and abnormal eye features.
Facts
Classification
ICD-10 ChapterXVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 1 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) First Described Sources
1. World Health Organization ICD-10: ICD-10 Version:2019 - Q80-Q89
World Health Organization ICD-10Category Q87.8Quote, Category Q87.8
Q87.8 Other specified congenital malformation syndromes,
View the Source 2. Cardiofaciocutaneous syndrome (Wikipedia)
Wikipedia intro: CFC syndrome: 'extremely rare genetic disorder...RASopathies'; 'first described in 1986'View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.